ArticlePediatric cardiology2026
Neurological Development in Very Low Birth Weight Infants with Congenital Heart Disease at 3 Years of Age: A Japanese Multicenter Study.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurodevelopmental impairment is an increasing concern in very low birth weight (VLBW) infants with congenital heart disease (CHD). However, their prevalence and associated risk factors remain poorly defined. We aimed to investigate the neurodevelopmental outcomes and identify risk factors for impairment in this vulnerable population. This multicenter cohort study included VLBW infants born between 2006 and 2014 without genetic or known anomalies. Neurodevelopment was assessed at three years of age using the Kyoto Scale of Psychological Developmental (KSPD). Poor neurodevelopment was defined as a total developmental quotient (DQ) < 70, a diagnosis of cerebral palsy, or clinical judgment in cases where the KSPD was not administered. Among 52 infants with CHD and 189 without, poor neurodevelopment outcomes were significantly more frequent in the CHD group (36.5% vs.16.4%, p = 0.003), particularly in those with serious CHD (54.9%). Multivariate logistic regression identified serious CHD and prolonged hospitalization (> 13 weeks) as independent risk factors. These findings highlight the need for early identification and multidisciplinary follow-up in this high-risk populations.
Indexed as
Identifiers
41109872What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.